First new 'quit-smoking' drug in 20 years shows promising results in US trial: ‘Hope and excitement’
Fox News
Achieve Life Sciences, Inc., a Seattle, Washington-based pharmaceutical company, has announced positive results from the Phase 3 trial of a smoking cessation drug called cytisinicline.
Smoking claims more than seven million lives each year worldwide, making it the leading cause of preventable death, according to the Centers for Disease Control and Prevention (CDC). By 2030, the number of casualties is expected to rise to eight million per year. "The smoking epidemic has been long overlooked." "The currently available treatments have a history of ‘black box warnings’ and high rates of adverse events." "The availability of this medication for nicotine dependence could have positive far-reaching effects." Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
Medications to help people quit smoking have been limited.
Critically endangered whale seen off California coast: 'Every sighting is incredibly valuable to us'
In a rare sighting recently, the endangered North Pacific right whale was spotted off the coast of California by a marine wildlife team near Cordell Bank National Marine Sanctuary.